Reichel, Andreas

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Mathieu, C., Dandona, P., Gillard, P., Senior, P., Hasslacher, C., Araki, E., Lind, M., Bain, S. C., Jabbour, S., Arya, N., et al. (2018) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 252

Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection: Miniperspective

O’ Donovan, D. H., De Fusco, C., Kuhnke, L., & Reichel, A. (2023) · Journal of Medicinal Chemistry

Computational Drug Discovery MethodsDrug Solubulity and Delivery Systems

Cited by 83

Clinical recommendations for the use of the ambulatory glucose profile in diabetes care

Kröger, J., Reichel, A., Siegmund, T., & Ziegler, R. (2020) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchDiabetes Management and Education

Cited by 51

Potential and Limits of Kidney Cells for Evaluation of Renal Excretion

Lechner, C., Mönning, U., Reichel, A., & Fricker, G. (2021) · Pharmaceuticals

Drug Transport and Resistance MechanismsBarrier Structure and Function Studies

Cited by 20

Extension of the Mechanistic Tissue Distribution Model of Rodgers and Rowland by Systematic Incorporation of Lysosomal Trapping: Impact on Unbound Partition Coefficient and Volume of Distribution Predictions in the Rat

Schmitt, M. V., Reichel, A., Liu, X., Fricker, G., & Lienau, P. (2021) · Drug Metabolism and Disposition

Computational Drug Discovery MethodsPharmacogenetics and Drug Metabolism

Cited by 19